Table 1.
Conditions from ozone exposure/reactive oxygen species*
| Authors, year (reference) | Pollutant exposure | Type of study | Respiratory condition of focus | Co-existing conditions | Number of subjects | Types of analysed markers and results |
|---|---|---|---|---|---|---|
| Alexis et al., 2008 [36] | Ozone | Double-blind, placebo-controlled, randomised, three-period crossover study | O3-induced lung function decline | N/A | 8 female (9 male) | CC16 levels: statistically significantly increased pre-vs post-O3 exposure. |
|
|
|
|
|
|
|
SP-D levels: not statistically significantly altered pre-vs post-O3 exposure. |
| Bennet et al., 2016 [37] | Ozone | Randomised controlled exposure study | O3-induced lung function decline | Obese | 19 females | IL-6 levels: increased in healthy subjects’ pre-vs post-O3 exposure as well as in obese subjects but to a greater degree. |
| FP significantly reduced the percent of neutrophils in sputum by 18% and 35% for 0.5 mg and 2 mg FP, respectively. |
||||||
|
|
|
|
|
|
|
FP also significantly reduced the total number of neutrophils per milliliter of sputum by 14% and 43% for 0.5 mg and 2 mg FP, respectively. |
| Arjomandi et al., 2018 [38] |
Ozone |
Randomised crossover-controlled exposure study, MOSES study |
O3-induced lung function decline |
Geriatric population; exercise intervention |
52 females (35 males) |
CC16 levels: four hours post-exposure, significantly increased pre-vs post-O3 exposure dependent on the concentration. |
| Balmes et al., 2019 [8] | Ozone | Randomised double-blind crossover study, MOSES study† | O3-induced lung function decline | Geriatric population; exercise intervention | 52 females (35 males) | CRP, IL-6, 8-isoprostane, or P-selectin: no change. |
|
|
|
|
|
|
|
Nitrotyrosine: decreased after 120 ppb ozone. |
| Rich et al., 2020 [39] | Ozone | Randomised double-blind crossover study, MOSES study† | O3-induced lung function decline | Geriatric population; exercise intervention | 52 females (35 males) | After extending the time for pre-collection and standardising for ambient air pollution, results changed. |
|
|
|
|
|
|
|
Increasing ambient NO2, CO, and PES altered pulmonary function responses in a concentration-dependent manner which means previous MOSES studies are accurately measuring markers’ relationships. |
| Chamitava et al., 2020 [40] |
ROS | Observational study | COPD, chronic bronchitis, and asthma | Some smokers | Current asthma: 212 females. Past asthma: 84 females. Chronic bronchitis: 50 females. Controls: 2270 females | Chronic bronchitis subjects showed a higher rate of expression of oxidative stress biomarkers compared to asthmatic subjects. |
| s |
Asthmatics: blood leukocytes, basophils, and eosinophils heightened with ozone exposure. |
|||||
| Chronic bronchitis: glutathione and lymphocytes more heightened than normal. |
C16 – club cell secretory protein 16, CO – carbon monoxide, COPD – chronic obstructive pulmonary disorder, CRP: C-reactive protein, FP – fluticasone propionate, IL-6 – interleukin 6, MOSES – Multicenter Ozone Study in oldEr Subjects, NO2 – nitrogen dioxide, O3 – ozone
PES – potential environmental susceptibility, ppb – parts per billion, ROS – reactive oxygen species, SP-D – surfactant protein D
*Potential ozone-related inflammation candidates: CC16, nitrotyrosine, and IL-16 dysregulated.
†Same trial as above, different marker analysis.